omega-n-methylarginine has been researched along with uric acid in 5 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (uric acid) | Trials (uric acid) | Recent Studies (post-2010) (uric acid) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 27,980 | 1,717 | 9,982 |
Protein | Taxonomy | omega-n-methylarginine (IC50) | uric acid (IC50) |
---|---|---|---|
Solute carrier family 2, facilitated glucose transporter member 9 | Homo sapiens (human) | 300 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deby, C; Deby-Dupont, G; Lamy, M; Mouithys-Mickalad, A; Nys, M | 1 |
Ali, SF; Imam, SZ; Mayeux, PR; Zhang, C | 1 |
Adwani, SH; Breukels, O; Maxwell, SR; Waring, WS; Webb, DJ | 1 |
Maxwell, SR; McKnight, JA; Waring, WS; Webb, DJ | 1 |
Lennon, R; Lerman, A; Lerman, LO; Mathew, V; Nelson, RE; Prasad, A; Pumper, GM; Raichlin, E; Reriani, M; Rihal, C | 1 |
3 trial(s) available for omega-n-methylarginine and uric acid
Article | Year |
---|---|
Hyperuricaemia does not impair cardiovascular function in healthy adults.
Topics: Acetylcholine; Adolescent; Adult; Baroreflex; Blood Pressure; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Humans; Hyperuricemia; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Pulse; Uric Acid; Vascular Resistance; Vasodilator Agents | 2004 |
Lowering serum urate does not improve endothelial function in patients with type 2 diabetes.
Topics: Acetylcholine; Adult; Brachial Artery; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relationship, Drug; Down-Regulation; Endothelium, Vascular; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Placebos; Urate Oxidase; Uric Acid | 2007 |
Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis.
Topics: Adult; Atrasentan; Blood Glucose; Blood Pressure; Coronary Artery Disease; Coronary Circulation; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Female; Follow-Up Studies; Heart Rate; Humans; Kidney; Lipoprotein(a); Male; Microcirculation; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Pyrrolidines; Receptor, Endothelin A; Triglycerides; Uric Acid | 2010 |
2 other study(ies) available for omega-n-methylarginine and uric acid
Article | Year |
---|---|
Oxidative processes in human promonocytic cells (THP-1) after differentiation into macrophages by incubation with Chlamydia pneumoniae extracts.
Topics: Anti-Bacterial Agents; Biphenyl Compounds; Carcinogens; Cell Differentiation; Cell Line; Chlamydophila pneumoniae; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Gas Chromatography-Mass Spectrometry; Humans; Hydrogen Peroxide; Macrophages; Models, Chemical; Monocytes; NADPH Oxidases; Nitric Oxide Synthase; omega-N-Methylarginine; Onium Compounds; Oxygen; Sulfhydryl Compounds; Superoxide Dismutase; Superoxides; Tetradecanoylphorbol Acetate; Uric Acid; Vitamin E | 2001 |
Peroxynitrite and the regulation of Na(+),K(+)-ATPase activity by angiotensin II in the rat proximal tubule.
Topics: Angiotensin II; Animals; Deferoxamine; Dose-Response Relationship, Drug; Kidney Tubules, Proximal; Male; Nitrates; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Reactive Nitrogen Species; Sodium-Potassium-Exchanging ATPase; Superoxide Dismutase; Uric Acid | 2002 |